Genetic Regulation of the Capacity to Make Immunoglobulin G to Pneumococcal Capsular Polysaccharides

Journal of Investigative Medicine

Volumn 45, Issue 2, 1997, Pages 57-68

  Musher, Daniel M ^a,d   Groover, Jean E ^a   Watson, David A ^b   Pandey, Janardan P ^e   Rodriguez Barradas, Maria C ^a   Baughn, Robert E ^a   Pollack, Marilyn S ^a   Graviss, Edward A ^a   De Andrade, Mariza ^c   Amos, Christopher I ^c  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e NONE

Author keywords

Antibody; Capsular polysaccharide; IgG; Streptococcus pneumoniae; Vaccination

Indexed keywords

BACTERIAL VACCINE; BACTERIUM ANTIBODY; IMMUNOGLOBULIN ALLOTYPE; IMMUNOGLOBULIN G; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; ANIMAL; ANTIBODY PRODUCTION; ARTICLE; BLOOD; CAUCASIAN; CHROMOSOME MAP; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGY; JEW; MIDDLE AGED; MOUSE; PEDIGREE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; BACTERIAL VACCINES; CHROMOSOME MAPPING; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPEAN CONTINENTAL ANCESTRY GROUP; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOGLOBULIN ALLOTYPES; IMMUNOGLOBULIN G; JEWS; MICE; MIDDLE AGED; PEDIGREE; PNEUMOCOCCAL VACCINES;

EID: 0031063287     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Heffron R. Pneumonia: with special reference to pneumococcus lobar pneumonia. A Commonwealth Fund Book, copyright 1939, Cambridge. Reprinted by Harvard University Press, Cambridge, 1979.
2. White B. The biology of pneumococcus. The bacteriologic, biochemical and immunological characters and activities of Diplococcus pneumuniae. A Commonwealth Fund Book, copyright 1938. Cambridge. Reprinted by Harvard University Press, Cambridge, 1979.
3. Austrian R. Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. Rev Infect Dis 1981;(3 Suppl):S1-17.
4. Spika JS, Fedson DS, Facklam RR. Pneumococcal vaccination: controversies and opportunities. Infect Dis Clin North Amer 1990;4:11-27.
5. Musher DM, Watson DA, Dominguez E. Pneumococcal vaccination: work to date and future prospects. Amer J Med Sci 1990;300:45-52.
6. Fedson DS, Musher DM. Pneumococcal vaccine. In: Plotkin S, Mortimer EA. Vaccines. Philadelphia: WB Saunders, 1994:517-64.
7. Hirschmann JV, Lipsky BA. The pneumococcal vaccine after 15 years of use. Arch Intern Med 1994;154:373-7.
8. Fine MJ, Smith MA, Carson CA, Meffe F, Sankey SS, Weissfeld LA, Detsky AS, Kapoor WN. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials Arch Intern Med 1994;154:2666-77.
9. Smillie WG, Wornock GH, White HJ. A study of a type I pneumococcus epidemic at the State Hospital at Worcester, Mass. Am J Publ Health 1938;28:293-302.
10. MacLeod CM, Hodges RG, Heidelberger M, Bernhard WG. Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. J Exp Med 1945;82:445-65.
11. Shapiro ED, Berg AT, Austrian R, Schroeder D, Parcells V, Margolis A, Adair RK, Clemens JD. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325:1453-60.
12. Heidelberger M, MacLeod CM, Kaiser SJ, Robinson B. Antibody formation in volunteers following injection of pneumococci or their type-specific polysaccharides. J Exp Med 1946;83:303-20.
13. Austrian R. The assessment of pneumococcal vaccine. N Engl J Med 1980;303:578-80.
14. Robbins JD, Austrian R, Lee CJ, Rastogi SC, Schiffman G, Henrichsen J, Makela PH, Broome CV, Facklam RR, Tiesjema RH, Parke JC Jr. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 1983;148:1136-59.
15. Schiffman G, Douglas RM, Bonner MJ, Robbins M, Austrian R. A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques. J Immunol Methods 1980;33:133-44.
16. Klein RS, Selwyn PA, Maude D, Pollard C, Freeman K, Schiffman GS. Response to pneumococcal vaccine among asymptomatic heterosexual partners of persons with AIDS and intravenous drug users infected with human immunodeficiency virus. J Infect Dis 1989;1160:826-31.
17. Sorensen UBS, Henrichsen J. C-polysaccharide in a pneumococcal vaccine. Acta Path Microbiol Immunol Scand 1984;92:351-6.
18. Koskela M. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination. Pediatr Infect Dis J 1987;6:519-26.
19. Musher DM, Watson DA, Baughn RE. Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection? J Infect Dis 1990;161:736-40.
20. Szu SC, Schneerson R, Robbins JB. Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae fail to protect mice from lethal infection with encapsulated pneumococci. Infect Immun 1986;54:448-53.
21. Musher DM, Johnson BJ, Watson DA. Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4. Infect Immun 1990;58:3871-6.
22. Nielsen SV, Sorensen UBS, Henrichsen J. Antibodies against pneumococcal C-polysaccharide are not protective. Microb Pathog 1993;14:299-305.
23. Siber GR, Priehs C, Madore DV. Standardization of antibody assays for measuring the response to pneumococcal infection and immunization. Pediatr Infect Dis J 1989;8:S84-S91.
24. Musher DM, Luchi M, Watson DA, Hamilton R, Baughn RE. Pneumococcal polysaccharide vaccine in young adults and older bronchitics. determination of IgG responses by ELISA and the effect of adsorption of serum with nontype-specific cell wall polysaccharide. J Infect Dis 1990;161:728-35.
25. Goldblatt D, Levinsky RL, Turner MW. Role of cell wall polysaccharide in the assessment of IgG antibodies to the capsular polysaccharides of Streptococcus pneumoniae in childhood. J Infect Dis 1992;166:632-4.
26. Baker PJ, Bailey DW, Fauntleroy MB, Stashak PW, Caldes G, Prescott B. Genes on different chromosomes influence the antibody response to bacterial antigens. Immunogenet 1985;22:269-76.
27. Kohler PF, Rivera VJ, Eckert ED, Bouchard TJ, Heston LL. Genetic regulation of immunoglobulin and specific antibody levels in twins reared apart. J Clin Invest 1985;75:883-8.
28. Konradsen HB, Henrichsen J, Wachmann H, Holm N. The influence of genetic factors on the immune responses as judged by pneumococcal vaccination of mono- and dizygotic Caucasian twins. Clin Exp Immunol 1993;92:532-6.
29. Giebink S, chairman. Proceedings of the International Workshop on Immunologic Assays for Pneumococcal Vaccines; 1994 October 17-18; Atlanta. Cosponsored by the World Health Organization, Centers for Disease Control, National Institutes of Allergy and Infectious Diseases, and Food and Drug Administration.
30. Vyas GN, Fudenberg HH, Pretty HM, Gold ER. A new rapid method for genetic typing of human immunoglobulins. J Immunol 1968;100:274-9.
31. Zachary AA, Teresi GA, eds. ASHI Laboratory Manual, American Society for Histocompatibility and Immunogenetics, 2nd ed. 1990.
32. Hasstedt SJ. Pedigree Analysis Package, Revision 4.0, 1994.
33. Musher DM, Groover JE, Graviss EP, Baughn RE. The lack of association between aging and postvaccination levels of IgG antibody to capsular polysaccharides of Streptococcus pneumoniae. Clin Infect Dis 1996;22:165-7.
34. vanDam JEG, Fleer A, Snippe H. Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides. Antonie Van Leeuwenhoek 1990;58:1-47.
35. Granoff DM, Pandey JP, Boies E, Squires J, Munson RS, Suarez B. Response to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine and risk of Haemophilus meningitis in children with the Km(1) immunoglobulin allotype. J Clin Invest 1984;74:1708-14.
36. Granoff DM, Suarez BK, Pandey JP, Shackelford PG. Genes associated with the G2m(23) immunoglobulin allotype regulate the IgG subclass responses to Haemophilus influenzae type b polysaccharide vaccine. J Infect Dis 1988;157:1142-9.
37. Hilleman MR, Carlson AJ Jr., McLean AA, Vella PP, Weibel RE, Woodhour AF. Streptococcus pneumoniae polysaccharide vaccine. age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. Rev Infect Dis 1981;(3 Suppl):S31-42.
38. Amsbaugh DF, Hansen CT, Prescott B, Stashak PW, Barthold DR, Baker PJ. Genetic control of the antibody response to Type III pneumococcal polysaccharide. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness. J Exp Med 1972;136:931-49.
39. Pandey JP, Fudenberg HH, Virekka G, Kyong CU, Loadholt CB, Galbraith RM, Gotschlich EG, Parke JG. Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and Meningococcus polysaccharides. Lancet 1979;1:190-2.
40. Ambrosino DM, Morell A, Vassalli G, de Lange GG, Skvaril F, Siber GR. Correlations of G2m(n) and Km(1) allotypes with subclass and light-chain specific antibody. Monogr Allergy 1988;23:244-55.
41. Granoff DM, Holmes SJ. G2m(23) immunoglobulin allotype and immunity to Haemophilus influenzae type b. J Infect Dis 1992;165 (Suppl):S66-9.
42. Pandey JP, Zollinger WD, Fudenberg HH, Loadholt CB. Immunoglobulin allotypes and immune response to meningococcal group B polysaccharide. J Clin Invest 1981;68:1378-80.
43. Pandey JP, Ambrosch F, Fudenberg HH, Stanek G, Wiedermann G. Immunoglobulin allotypes and immune response to meningococcal polysaccharides A and C. J Immunogenet 1982;9:25-9.
44. Morell A, Vassalli G, de Lange GG. Ig allotype-linked regulation of class and subclass composition of natural antibodies to group A streptococcal carbohydrate. J Immunol 1989;142:2495-500.
45. Pandey JP, Baker CJ, Kasper DL, Fudenberg HH. Two unlinked genetic loci interact to control the human immune response to type III group B streptococcal antigen. J Immunogenet 1984;11:159-63.
46. Ambrosino DM, Schiffman G, Gotschlich EC, Schur PH, Rosenberg GA, DeLange GD, van Loghem E, Siber GR. Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. J Clin Invest 1985;75:1935-42.
47. Sarvas H, Rautonen N, Sipinen S, Makela O. IgG subclass of pneumococcal antibodies - effect of allotype G2m(n). Scand J Immunol 1990;29:229-37.
48. Baker PJ, Amsbaugh F, Prescott B, Stashak PW. Genetic control of the antibody response to type III pneumococcal polysaccharide in mice. III. Analysis of genes governing the expression of regulatory T cell activity. J Immunogenet 1976;3:275-86.
49. Ambrosino DM, Barrus VA, DeLange GG, Siber GR. Correlation of the Km(1) immunologlobulin allotype with anti-polysaccharide antibodies in Caucasian Adults. J Clin Invest 1986;78:361-5.
50. Alper CA, Kruskall MS, Marcus-Bagley D, Craven DE, Katz AJ, Brink SJ, Dienstag JL, Awdeh A, Yunis EJ. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989;321:708-12.
51. Kruskall MS, Alper CA, Awdeh Z, Yunis EJ, Marcus-Bagley D. The immune response to hepatitis B vaccine in humans. inheritance patterns in families. J Exp Med 1992;175:495-502.
52. Deulofeut R, Salazar J, Deulofeut H, Yunis DE, Marcus-Bagley D, Awdeh Z, Alper CA, Yunis EJ. T-cell precursor frequencies to HBsAg by limiting dilution strongly suggest a defect in T-cells rather than in antigen presenting cells. Immunology 1993;37:32.
53. Kantor AB, Leonore AH. Origin of murine B cells lineages. Ann Rev Immunol 1993;11:501-38.
54. Hiernaux JR, Goidl EA, Martin McEvoy SJ, Siashak PW, Baker PJ, Holmes KL. Characterization of the immunodeficiency of RIIIS/J mice. I. Association with the Ly-1 B cell lineage. J Immunol 1989;142:1813-7.
55. Baker PJ. Suppressors T cells. American Society for Microbology News 1993;59:123-8.
56. Sarvas H, Rautonen N, Kayhty H, Kallio M, Makela O. Effect of Gm allotypes on IgG2 antibody responses and IgG2 concentrations in children and adults. Int Immunol 1990;2:317-22.
57. Weinberg GA, Granoff DM. Immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children with conditions associated with impaired antibody responses to type b polysaccharide vaccine. Pediatrics 1990;85(suppl.):654-61.